MedPath

SABRIL

These highlights do not include all the information needed to use SABRIL safely and effectively. See full prescribing information for SABRIL . SABRIL ( vigabatrin ) t ablet s , for oral use SABRIL ( vigabatrin ) for o ral s olution Initial U.S. Approval: 2009

Approved
Approval ID

a5d389d2-d0e1-4395-a2a2-b552808e7f98

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Sep 30, 2025

Manufacturers
FDA

Lundbeck Pharmaceuticals LLC

DUNS: 009582068

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

vigabatrin

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code67386-111
Application NumberNDA020427
Product Classification
M
Marketing Category
C73594
G
Generic Name
vigabatrin
Product Specifications
Route of AdministrationORAL
Effective DateSeptember 30, 2025
FDA Product Classification

INGREDIENTS (8)

VIGABATRINActive
Quantity: 500 mg in 1 1
Code: GR120KRT6K
Classification: ACTIB
HYPROMELLOSESInactive
Code: 3NXW29V3WO
Classification: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30
Classification: IACT
CELLULOSE, MICROCRYSTALLINEInactive
Code: OP1R32D61U
Classification: IACT
POLYETHYLENE GLYCOL, UNSPECIFIEDInactive
Code: 3WJQ0SDW1A
Classification: IACT
TITANIUM DIOXIDEInactive
Code: 15FIX9V2JP
Classification: IACT
POVIDONEInactive
Code: FZ989GH94E
Classification: IACT
SODIUM STARCH GLYCOLATE TYPE A POTATOInactive
Code: 5856J3G2A2
Classification: IACT

Drug Labeling Information

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

LOINC: 51945-4Updated: 10/20/2021

PRINCIPAL DISPLAY PANEL****
NDC 67386-111-01
Sabril®
(vigabatrin) Tablets
500 mg
DISPENSE THE ENCLOSED MEDICATION

GUIDE WITH EACH PRESCTIPTION.
****Rx only
100 Tablets

PRINCIPAL DISPLAY PANEL NDC 67386-111-01 Sabril® (vigabatrin) Tablets 500 mg DISPENSE THE ENCLOSED MEDICATION GUIDE WITH EACH PRESCTIPTION. Rx only 100 Tablets


DESCRIPTION SECTION

LOINC: 34089-3Updated: 10/20/2021

11****DESCRIPTION

SABRIL (vigabatrin) is an oral antiepileptic drug and is available as white film-coated 500 mg tablets and as a white to off-white granular powder for oral solution in packets of 500 mg.

The chemical name of vigabatrin, a racemate consisting of two enantiomers, is (±) 4-amino-5-hexenoic acid. The molecular formula is C6H11NO2 and the molecular weight is 129.16. It has the following structural formula:

![The chemical structure of vigabatrin.](/dailymed/image.cfm?name=sabril- tablets-1.jpg&id=900457)

Vigabatrin is a white to off-white powder which is freely soluble in water, slightly soluble in methyl alcohol, very slightly soluble in ethyl alcohol and chloroform, and insoluble in toluene and hexane. The pH of a 1% aqueous solution is about 6.9. The n-octanol/water partition coefficient of vigabatrin is about 0.011 (log P=-1.96) at physiologic pH. Vigabatrin melts with decomposition in a 3-degree range within the temperature interval of 171ºC to 176ºC. The dissociation constants (pKa) of vigabatrin are 4 and 9.7 at room temperature (25ºC).

Each SABRIL tablet contains 500 mg of vigabatrin. The inactive ingredients are hydroxypropyl methylcellulose, magnesium stearate, microcrystalline cellulose, polyethylene glycols, povidone, sodium starch glycolate, and titanium dioxide.

SABRIL for oral solution is available as a white to off-white granular powder. Each packet contains 500 mg of vigabatrin. The inactive ingredient is povidone.

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

SABRIL - FDA Drug Approval Details